共 86 条
[1]
Bernstein CN(2007)Hospitalization-based major co morbidity of inflammatory bowel disease in Canada Can J Gastroenterol Hepatol 21 507-511
[2]
Nabalamba A(2008)Rising prevalence of venous thromboembolism and its impact of mortality among hospitalized inflammatory bowel disease patients Am J Gastroenterol 103 2272-2280
[3]
Nguyen GC(2010)Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study Lancet 375 657-663
[4]
Sam J(2011)Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study Gut 60 937-943
[5]
Grainge MJ(2013)Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease Aliment Pharmacol Ther 37 953-962
[6]
West J(2007)Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom Arch Intern Med 167 935-943
[7]
Card TR(2008)Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th Edition) Chest 133 381S-453S
[8]
Kappelman MD(2010)Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee Am J Gastroenterol 105 501-523
[9]
Horvath-Puho E(2014)Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian association of gastroenterology Gastroenterology 146 835-848.e6
[10]
Sandler RS(2013)A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States J Clin Gastroenterol 47 e1-e6